Obinutuzumab significantly outperforms placebo in improving outcomes for adults with active systemic lupus erythematosus, enhancing disease management.

by Furie RA, Dall'Era M (...) Askanase AD et 22 al. in N Engl J Med

📖 read the article: https://www.nejm.org/doi/10.1056/NEJMoa2516150